Lit Review

Monitoring CAR-T cells activation and their cytotoxicity

Download  Lit Review
Mockup CAR-T cells literature review

CAR-T cells - a new immunotherapy strategy used in the destruction of tumor cells

CAR-T cells (for T cells carrying a chimeric receptor) are involved in gene therapies. These new treatments are currently used in onco-hematology. The cells are made from the patient's own T-lymphocytes. When genetically modified and reinjected, they are capable of specifically recognizing and destroying cancer cells after binding to the tumor antigen by releasing a mixture of cytokines and pro-inflammatory chemokines.

This literature review, based on several scientific publications, focuses on the activation of CAR-T cells in vitro, monitored by using our homogeneous technologies such as AlphaLISA® and HTRF®. These methods are simple, sensitive, and robust, while consuming a minimum of samples and providing results faster than ELISA tests.

See below the different points monitored by our technologies in this literature review:

  • Measurement of cell proliferation and cytokine release
  • Cytotoxicity tests: DELFIA Eu TDA in CAR-T co-culture
  • Cytotoxicity percentage measurement of CD19-expressing target cell lines
  • Measurement of IFN concentrations-γ

Download  Lit Review

We are committed to your privacy. Revvity needs the contact information you provide us to keep you aware about relevant content, products, and services. You may unsubscribe from these communications at any time. For more information check out our  Privacy Policy.